<code id='CA5B6272B4'></code><style id='CA5B6272B4'></style>
    • <acronym id='CA5B6272B4'></acronym>
      <center id='CA5B6272B4'><center id='CA5B6272B4'><tfoot id='CA5B6272B4'></tfoot></center><abbr id='CA5B6272B4'><dir id='CA5B6272B4'><tfoot id='CA5B6272B4'></tfoot><noframes id='CA5B6272B4'>

    • <optgroup id='CA5B6272B4'><strike id='CA5B6272B4'><sup id='CA5B6272B4'></sup></strike><code id='CA5B6272B4'></code></optgroup>
        1. <b id='CA5B6272B4'><label id='CA5B6272B4'><select id='CA5B6272B4'><dt id='CA5B6272B4'><span id='CA5B6272B4'></span></dt></select></label></b><u id='CA5B6272B4'></u>
          <i id='CA5B6272B4'><strike id='CA5B6272B4'><tt id='CA5B6272B4'><pre id='CA5B6272B4'></pre></tt></strike></i>

          Home / Wikipedia / explore

          explore


          explore

          author:entertainment    Page View:83
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In